Screener
Castle Biosciences CSTL Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's enterprise value?
- Castle Biosciences (CSTL) reported enterprise value of $702.86M in Q1 2026.
- How has Castle Biosciences's enterprise value changed year-over-year?
- Castle Biosciences's enterprise value increased by 38.6% year-over-year, from $507.01M to $702.86M.
- What is the long-term trend for Castle Biosciences's enterprise value?
- Over 4 years (2021 to 2025), Castle Biosciences's enterprise value has grown at a 8.4% compound annual growth rate (CAGR), from $763.3M to $1.06B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Castle Biosciences's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude